First-line systemic therapy for advanced or metastatic esophageal squamous cell carcinoma: clinical implications for treatment selection after KEYNOTE-590, CheckMate 648, and RATIONALE-306

发表于 2026-9-23 16:31:15

期刊：Clinical Journal of Gastroenterology

文献作者：Tamotsu Sagawa; Hiroyuki Nagashima; Koshi Fujikawa

出版日期：--

DOI号：10.1007/s12328-026-02447-5

下载链接：https://link.springer.com/conten ... 328-026-02447-5.pdf

文献链接：https://doi.org/10.1007/s12328-026-02447-5

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-9-23 16:31:16

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Springer] First-line systemic therapy for advanced or metastatic esophageal squamous cell carcinoma: clinical implications for treatment selection after KEYNOTE-590, CheckMate 648, and RATIONALE-306

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Springer] First-line systemic therapy for advanced or metastatic esophageal squamous cell carcinoma: clinical implications for treatment selection after KEYNOTE-590, CheckMate 648, and RATIONALE-306 一键复制

已采纳